| Natural plant extract tubeimoside I induces cytotoxicity via the mitochondrial pathway in human normal liver cells. | |
| | |
MedLine Citation:
|
PMID: 21537846 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Tubeimoside I (TBMS I) is a natural compound extracted from Bolbostemma paniculatum (Maxim.) Franquet (Cucurbitaceae), a traditional Chinese herbal medicine widely used for the treatment of inflammation. Recently, it has been suggested that TBMS I may be a potent anticancer agent for a variety of human cancers. However, TBMS I is known to distribute preferentially in the liver, and thus may harm normal liver cells if it is delivered systemically for cancer treatment. This safety concern warrants careful evaluation of the hepatotoxicity of TBMS I to normal liver cells, which to date has not been carried out. Here, we report the cytotoxic effects of TBMS I on one type of normal liver cells (L-02 cells), and the associated molecular events as underlying mechanisms. Cultured human normal liver L-02 cells were treated with TBMS I at concentrations of 0, 15 and 30 µM for 24, 48 and 72 h, respectively. Subsequently, the cell survival rate was evaluated by the MTT dye method, and several key molecular events associated with apoptosis were assayed, including mitochondrial depolarization, release of cytochrome c (cyt-c), activation of caspases, and the balance between Bax and Bcl-2 protein expression. Our results indicate that TBMS I inhibited the proliferation of L-02 cells in a dose- and time-dependent manner. The TBMS I-induced growth inhibition of L-02 cells was accompanied by the collapse of mitochondrial membrane potential, release of cyt-c from the mitochondria to the cytosol, activation of caspase-9 and -3, decrease of anti-apoptotic protein Bcl-2 levels and increase of the pro-apoptotic protein Bax levels, all indicative of apoptosis through the mitochondrial pathway. Taken together, these results confirm that TBMS I has a significant apoptotic effect on normal liver L-02 cells, which may be significant to its clinical applications. |
| | |
Authors:
|
Yashu Wang; Linhong Deng; Yajie Wang; Hongzhe Zhong; Xuemei Jiang; Jun Chen |
Related Documents
:
|
12846806 - Cell-cycle control of plasma cell differentiation and tumorigenesis. 19395856 - Nfatc2 ser170 phosphorylation marks mitosis in development and es cells. 8950986 - Expression of human muts homolog 2 (hmsh2) protein in resting and proliferating cells. 7974746 - Developmental modification of the drosophila cell cycle. 2428686 - Origin of the inner cell mass in mouse embryos: cell lineage analysis by microinjection. 12200256 - Evolution of fast development of planktonic embryos to early swimming. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-28 |
Journal Detail:
|
Title: Molecular medicine reports Volume: - ISSN: 1791-3004 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-5-3 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101475259 Medline TA: Mol Med Report Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Key Laboratory of Biorheological Science and Technology, Ministry of Education, and Bioengineering College, Chongqing University, Chongqing 400044, P.R. China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: RhoC protein stimulates migration of gastric cancer cells through interaction with scaffold protein ...
Next Document: Management of Meningeal Neoplasms: Meningiomas and Hemangiopericytomas.